Flu Vaccine May Not Protect Against Main Flu Strain

US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19

Influenza A(H3N2) Outbreak on a University Campus — Michigan, October–November 2021

Studying the Effect of Amino Acid Substitutions in the M2 Ion Channel of the Influenza Virus on the Antiviral Activity of the Aminoadamantane Derivative In Vitro and In Silico

COVID Pandemic May Have Driven a Flu Strain Into Extinction

NFID: More Patients with Chronic Conditions Need Flu Jab

Potential Association Between Dietary Fibre and Humoral Response to the Seasonal Influenza Vaccine

Role of CXCL5 in Regulating Chemotaxis of Innate and Adaptive Leukocytes in Infected Lungs Upon Pulmonary Influenza Infection

Clinical spectrum, risk factors, and outcomes of children with laboratory-confirmed influenza infection managed in a single tertiary hospital

Factors Predicting Influenza Vaccination Adherence Among Patients In Dialysis